Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of 6681.HK is 7.6 and suggests 68% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell